Grade: Pharmaceutical Grade

Factory Location: Xiamen, Fujian

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

Monthly Production Capacity: 1000kg

Packaging Information: 25kg/drum 1kg/bottle

Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/L

Product Information

 

Product name	Empagliflozin
CAS No.	864070-44-0
Molecular Formula	C23H27ClO7
Molecular Weight	450.91
Quality Standard	99.5% up by HPLC, Medical Grade
Appearance	White powder

 

COA of Empagliflozin

 

ITEMS	STANDARDS	RESULTS
Appearance	White to off-White Powder	Complies
Identification	HPLC	Complies
Melt Point	150 ~ 155 ℃	152.0 ~ 154.0 ℃
Loss on dry	≤0.5%	0.3%
Residue on ignition	≤0.1%	Complies
Heavy metals	≤10ppm	Complies
Water content	≤0.5%	0.32%
Optical rotation	+15 ~ +21	+19.5
Solubility in water	8-12mg/ 100ml	9mg/ 100ml
Solubility	soluble in methanol and DCM	Conformed
Related Substances	Total impurities ≤0.5% Single impurity（max）≤0.1%	0.23% 0.04%
Isomer	≤0.15%	0.09%
Particle size	D90＜20μ m	Complies
Assay(HPLC)	≥99.5%	99.86%
Residual solvents	Ethyl acetate≤0.5%	0.20%
	Dichloromethane≤0.6%	ND
	Ethyl alcohol≤0.5%	0.03%
	Methanol≤0.3%	ND
	ACN≤0.041%	ND
	Tetrahydrofurans≤0.072%	0.04%
	Methylbenzene≤0.089%	0.06%
Conclusion	Complies with specification.

 

Usage

 

Function of Empagliflozin

Empagliflozin tablet is a new type of hypoglycemic drug, which can reduce the blood sugar level of patients and protect the liver and kidney function of patients. In addition, it also has a certain protective effect on the cardiovascular system of patients. When Empagliflozin tablets are used alone, patients often have lower blood sugar levels than before, and hypoglycemia rarely occurs. It is recommended that patients pay attention to monitoring the blood glucose level during the oral administration of Empagliflozin tablets. If Empagliflozin is used alone, the blood sugar level is not lowered well, it can also be combined with metformin or acarbose or other Hypoglycemic drugs.